Compare GeneDx Holdings Corp (WGS) vs Western Union Co (WU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GeneDx Holdings Corp vs Western Union Co — how do they compare? GeneDx Holdings Corp trades at $67.33 (market cap $2.02B), while Western Union Co trades at $6.12 (market cap $1.97B). The key difference: GeneDx Holdings Corp and Western Union Co are close in size by market cap, and Western Union Co pays a 14.85% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold GeneDx Holdings Corp for 19 Days and Western Union Co for 96 Days on average.
| WGS | WU | |
|---|---|---|
Market Cap | $2.02B | $1.97B |
Volume | 734,640 | 10,235,212 |
Sector | Health | Financials |
52-Week High | $167.51 | $10.28 |
52-Week Low | $34.51 | $5.90 |
Typical Hold Time | 19 Days | 96 Days |
Enterprise Value | $2.05B | $1.88B |
Dividend Yield | — | 14.85% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GeneDx (WGS) trades at $67.73, down 1.17% with bearish technical signals despite recent earnings beats. The company shows strong revenue growth to $454M in 2026 but faces profitability challenges with a -23.4% net margin. Recent developments include new genomic testing products and hospital partnerships, while analyst consensus remains strongly bullish with a $81 price target.
The stock presents a growth story with expanding genomic testing volumes but carries significant execution risk given negative profitability metrics. Upside potential exists if management can translate revenue growth into sustainable profits, though current cash flow trends and high valuation multiples warrant caution for risk-averse investors.
Western Union (WU) trades at $6.33, up 3.6% today, with mixed technical signals showing a bullish overall trend but bearish moving averages. The stock shows strong profitability with a 43.97% ROE and attractive valuation at 5.1 P/E, though recent earnings misses and declining revenue from $4.5B in 2022 to $4.05B in 2025 raise concerns. The company's $200M efficiency plan and Intermex acquisition aim to revive growth amid competitive pressures.
WU presents a value opportunity with low multiples but faces execution risks from digital disruption and integration challenges. Analyst consensus is cautious with a $6.86 price target and only 12% buy ratings. The stock's upside depends on successful cost savings and regulatory approval of the Intermex deal, while downside risks include further revenue erosion and margin compression.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →About Western Union Co
Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.
Read more on WU →
